We found 170 records for "Licensing / acquisition"

Articles

Does the drug industry need a new pricing model?

12th January 2015

 Does the drug industry need a new pricing model?Articles

Various approaches have been taken to try to balance the rising costs of new medicines with tightening healthcare budgets, but few have proved effective long-term. Advances in drug development are...

Read more

20 People who shaped healthcare in 2014 (Part 4)

2nd January 2015

 20 People who shaped healthcare in 2014 (Part 4)Articles

In the final instalment of our review of 2014, Andrew McConaghie looks at how patient advocates in rare diseases and 'activist investors' have shaped healthcare – and will continue to...

Read more

Selling science to potential investors and partners

12th September 2014

 Selling science to potential investors and partnersArticles

Start-ups and biotechs often need the support of outside investors to take their innovations to the next level. So what are the considerations when preparing a presentation for these important...

Read more

Adaptive Licensing: Could patients be the answer to the data problem?

4th August 2014

 Adaptive Licensing: Could patients be the answer to the data problem?Articles

Patients could play a key role in generating the data required to make Europe's Adaptive Licensing a success.The timing of patient access to new medicines has always been one of...

Read more

News

Mylan set to fight Teva’s $40 billion takeover bid

22nd April 2015

 Mylan set to fight Teva’s $40 billion takeover bidNews

Teva has unveiled its long-anticipated takeover bid for rival generics firm Mylan, offering a deal worth $40 billion to shareholders.Already the world's largest maker of generic medicines, Teva believes a...

Read more

Mylan offers $28.9bn for Perrigo to bury Teva rumour

9th April 2015

 Mylan offers $28.9bn for Perrigo to bury Teva rumourNews

The flurry of M&A news this year shows no signs of abating, with Mylan proposing a $28.9 billion deal to acquire Ireland's Perrigo and create a powerhouse in generic and...

Read more

Mid-cap companies: pharma’s growth engine

8th April 2015

 Mid-cap companies: pharma’s growth engineNews

Some of the most exciting new drugs are being discovered by mid-sized pharma and biotech companies, and 2014 saw more of them reaping the benefits of marketing their own products.These...

Read more

Merck licenses Arvinas' protein-clearing technology

8th April 2015

 Merck licenses Arvinas' protein-clearing technologyNews

Merck & Co has signed a broad-ranging deal to develop drugs based on Arvinas' PROTAC technology, which causes proteins to be broken down and removed from cells.In contrast to traditional...

Read more

White Papers

All change for pharma and biotech partnerships

30th September 2013

 All change for pharma and biotech partnershipsWhite Papers

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D. In this original white paper, Phenestra shares its...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

2nd annual Pre-Filled Syringes America

27th April 2015 - 28th April 2015

2nd annual Pre-Filled Syringes America

Over 100 delegates from the world’s leading Pharmaceutical and Biotechnology businesses will meet in New Jersey at Pre-Filled Syringes America 2015 to discuss the latest achievements in the pre-filled syringe...

Read more

BioTrinity 2015

11th May 2015 - 13th May 2015

BioTrinity 2015

Where Great Minds, Smart Money and Key Dealmakers Meet BioTrinity is the leading European Biopartnering and Investment Conference. It provides the best opportunity to meet investors, senior licensing executives from...

Read more

ON Helix

14th July 2015

ON Helix

ON Helix is our translational research conference for the life science sector. ON Helix is a one day event aimed at informing delegates of how to turn early stage inventions and...

Read more

PharmaAfrica Market Access Conference

24th September 2015 - 25th September 2015

PharmaAfrica Market Access Conference

PharmaAfrica Market Access Conference is a leading event that will bring together experts to discuss the current market and patient access landscape in Africa, how it will be impacted by...

Read more

Press Releases

Arthur G. Cook (ZS Associates) publishes 2nd Edition with Gower

15th April 2015

Arthur G. Cook (ZS Associates) publishes 2nd Edition with Gower

  The eagerly awaited second edition of Arthur G. Cook's Forecasting for the Pharmaceutical Industry is now available from Gower.     Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as...

Read more

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more